Terumo (OTCMKTS:TRUMY) Shares Gap Down – Here’s What Happened

Terumo Corp. (OTCMKTS:TRUMY) gapped down prior to trading on Thursday. The stock had previously closed at $14.66, but opened at $13.92. Terumo shares last traded at $13.92, with a volume of 9,557 shares changing hands.

Wall Street Analyst Weigh In

Separately, Nomura raised Terumo from a “hold” rating to a “strong-buy” rating in a research note on Thursday, July 30th. One research analyst has rated the stock with a Strong Buy rating and one has issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Buy”.

Terumo Price Performance

The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.37 and a current ratio of 2.19. The company has a 50-day moving average of $15.17 and a 200-day moving average of $14.19. The stock has a market cap of $20.25 billion, a price-to-earnings ratio of 19.34 and a beta of 0.77.

Terumo (OTCMKTS:TRUMY) last posted its quarterly earnings data on Friday, August 7th. The company reported $0.30 earnings per share for the quarter, beating analysts’ consensus estimates of $0.17 by $0.13. Terumo had a net margin of 13.83% and a return on equity of 10.44%. The firm had revenue of $1.97 billion for the quarter, compared to analyst estimates of $1.84 billion. As a group, equities research analysts predict that Terumo Corp. will post 0.86 earnings per share for the current year.

About Terumo

Terumo Corporation is a Japan-based medical technology company that develops, manufactures and sells products used in hospitals, clinics and other healthcare settings. Founded in 1921 by a group of Japanese medical doctors, the company initially produced clinical thermometers and has since expanded into a global provider of medical devices and related services.

Terumo’s principal businesses include cardiac and vascular products, blood and cell technologies, and general hospital solutions.